उत्पाद वर्णन
Product introduction
Pegstim Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.
Pegstim Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked for regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.
The most common side effects of this medicine include bone pain, joint pain, headache, nausea, and muscle pain. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You must avoid driving or attention-seeking activity if you experience dizziness after taking this medicine.
How Pegfilgrastim 6 mg Injection WorksPegfilgrastim acts by stimulating the bone marrow to increase the production of neutrophils, a type of white blood cell that is essential for fighting infection. This support is especially crucial for patients with non-myeloid cancers undergoing chemotherapy, which often lowers neutrophil levels.
Ease of Administration and DosingAdministered as a subcutaneous injection, Pegfilgrastim is designed for once-per-chemotherapy cycle use, simplifying patient treatment schedules. The prefilled syringe allows convenient, single-use administration by healthcare providers in clinical settings.
Storage and Stability InformationTo maintain efficacy and safety, Pegfilgrastim injection must be stored at 2C to 8C and must not be frozen. The prefilled syringe remains stable for up to 24 months from the date of manufacture when stored as recommended.
FAQ's of Pegfilgrastim 6 Mg Injection:
Q: How is Pegfilgrastim 6 mg Injection administered?
A: Pegfilgrastim 6 mg Injection is given as a subcutaneous injection, generally by a healthcare professional, in a clinical setting. Each prefilled syringe contains a single dose and should not be reused.
Q: What is the benefit of using Pegfilgrastim during chemotherapy?
A: Pegfilgrastim reduces the risk of infection resulting from neutropenia, a common side effect of myelosuppressive chemotherapy. This helps patients avoid complications like febrile neutropenia and allows them to maintain recommended treatment schedules.
Q: When should Pegfilgrastim be injected after chemotherapy?
A: It is typically administered at least 24 hours after receiving chemotherapy and no sooner than 14 days before the next chemotherapy cycle. Always follow your healthcare provider's instructions for timing.
Q: Where should Pegfilgrastim injection be stored before use?
A: Store Pegfilgrastim at 2C to 8C in the refrigerator. Do not freeze the injection, and keep it away from direct light. If accidentally frozen, it must not be used.
Q: What precautions should I take before using Pegfilgrastim?
A: Inform your healthcare provider about any allergies, especially if you are hypersensitive to Pegfilgrastim or any excipients. It is not suitable for individuals with known hypersensitivity to its components.
Q: What should I do if I miss a dose of Pegfilgrastim?
A: If you miss a dose, contact your healthcare provider immediately. Do not administer the dose yourself without professional guidance, as timing is important for safety and effectiveness.